Personalized Treatments for Glaucoma Patients

Dear Colleagues,

Personalized treatments for glaucoma patients involve tailoring interventions to meet the unique needs of each individual. These treatments consider factors such as the type and severity of glaucoma, the patient’s age, overall health, and lifestyle. Common approaches include the use of eye drops to lower intraocular pressure (IOP), laser therapy to improve fluid drainage, and surgical options for advanced cases. Regular monitoring and follow-up visits are crucial to assess treatment effectiveness and make necessary adjustments. The goal of personalized treatments is to preserve vision and enhance the quality of life for glaucoma patients.

The topics may include:

• High intraocular pressure (IOP): Elevated IOP is a major risk factor for glaucoma development and progression. Managing and reducing IOP is a key focus of glaucoma treatment.
• Optic nerve damage: The extent of optic nerve damage is an important consideration in determining the appropriate treatment approach. More advanced damage may require more aggressive interventions.
• Visual field loss: The severity and progression of visual field loss play a role in determining the urgency and intensity of glaucoma treatment.
• Cup-to-disc ratio: A larger cup-to-disc ratio, which indicates a larger area of optic nerve damage, may indicate a higher risk and require more aggressive treatment.
• Medical conditions: Coexisting medical conditions, such as diabetes or cardiovascular disease, can complicate glaucoma treatment and may require additional considerations.
• Previous eye surgeries or injuries: Past eye surgeries or injuries can affect the choice of treatment options and their effectiveness.
• Post-surgical complications: The surgical treatment may cause transient or persistent hyphema (blood in the anterior chamber); intraocular pressure spikes or fluctuations; post-surgical hypotension; cataract formation, etc.
• Allergic reactions or side effects from eye drops, such as redness, itching, or burning sensation, in addition to systemic side effects from oral medications, including respiratory issues, heart problems, or gastrointestinal disturbances.
• Treatment of more aggressive and fast-progressive glaucoma, like PEXG or NVG.
• Treatment of normal tension glaucoma.
• The role of neuroprotection in glaucoma treatment.

Dr. Gloria Roberti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• glaucoma
• intraocular pressure (IOP)
• optic nerve damage
• visual field loss
• ophthalmoscopy
• angle closure glaucoma
• open-angle glaucoma
• primary glaucoma
• secondary glaucoma
• normal-tension glaucoma
• pigmentary glaucoma